New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

The U.S. FDA recently highlighted Amgen’s role in its real‑time clinical trials initiative, confirming the initiation of ...

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public. | A quantum ...

Amgen (NasdaqGS:AMGN) has been selected by the US Food and Drug Administration to participate in its real time clinical ...

Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing ...

Giredestrant plus everolimus does not increase treatment burden in advanced breast cancer, new safety and patient-reported outcome data from the evERA BC trial show.

TAGMO Clinical Readouts -- Initial results for head and neck, and upper GI adenocarcinoma cohorts are expected midyear, with ...

Amgen announced a $300 million expansion of its U.S. biologics manufacturing network. The plan includes a significant new ...

Dr. Howard Chang, fourth from left, Amgen's senior vice president global research & chief scientific officer, with fellows in the biotech company's new postbaccalaureate fellowship program. The ...

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during ...

Bill Baruch, Blue Line Capital founder and president, joins CNBC’s 'Halftime Report' to detail his latest portfolio moves.